This report aims to provide detailed insights into the global EMEA 3D CBCT Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
Revenue Growth Analysis:
[115 Pages Report] The EMEA 3D CBCT market is valued at 178.4 Million in 2017 and is expected to grow at a CAGR of 9.0%Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148086734
Key Factors Driving Market Growth:
The growing number of dentists is one of the major drivers for the growth of the dental CBCT market in this region. This increase, along with the subsequent establishment of new clinics and rising government spending on healthcare, has contributed to a growing demand for dental equipment like CBCT systems.
The dental segment accounted for the largest share of the EMEA 3D CBCT Market
On the basis of application, the market is broadly segmented into dental and non-dental applications. The dental applications segment further sub segmented into implantology, oral and maxillofacial surgery, orthodontics, endodontics, and other dental applications. The non-dental applications segment is sub segmented into ENT and radiology. The dental application segment accounted for the largest share of market in 2017. Large geriatric population in the European countries, technological enhancements, wide adoption of 3D CBCT systems in dental implant procedures, and the growing focus on the evaluation of post-treatment cases are factors attributed to the large share of dental application.
ENT segment accounted for the largest share of the non-dental application market
Based on the type, the non-dental application EMEA 3D CBCT Market is further segmented into ENT and radiology. In 2017, ENT segment accounted for the largest share of this market. This dominant share is attributed to the increasing use of CBT imaging in the diagnosis of ENT disorders due to advantages such as high spatial resolution, better visibility of small details, lower radiation exposure compared to traditional CT, patient convenience during examination, and compatibility of CBCT systems with surgical navigation/image-guided surgery systems during ear surgeries.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=148086734
Europe dominated the market:
Europe accounted for the largest share of the EMEA 3D CBCT Market in 2017, followed by the Middle East and Africa. The largest share of the European region is mainly attributed to the rising geriatric population, increasing awareness about oral healthcare, rising incidence of dental diseases, growing demand for advanced cosmetic dental procedures, growing dental tourism in some European countries, and the increasing number of dental clinics and hospitals in the region.
Even though the market is expected to grow at a high CAGR, the high cost of 3D CBCT system in addition to the lack of favorable reimbursement, is negatively impacting the adoption of new and advanced technologies in the EMEA 3D CBCT Market.
Key Players:
The key players in the EMEA 3D CBCT Market are Danaher Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group (Finland), VATECH (South Korea), CEFLA (Italy), J. MORITA CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan), and Genoray (South Korea).
